Sun Pharmaceutical Industries Limited (BOM:524715)
India
· Delayed Price · Currency is INR 1,664.00
+16.65 (1.01%)
At close: Jun 20, 2025
BOM:524715 Revenue
In the fiscal year ending March 31, 2025, Sun Pharmaceutical Industries had annual revenue of 525.78B INR with 8.42% growth. Sun Pharmaceutical Industries had revenue of 129.59B in the quarter ending March 31, 2025, with 8.14% growth.
Revenue
525.78B
Revenue Growth
+8.42%
P/S Ratio
7.60
Revenue / Employee
12.23M
Employees
43,000
Market Cap
3,995.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 525.78B | 40.82B | 8.42% |
| Mar 31, 2024 | 484.97B | 46.11B | 10.51% |
| Mar 31, 2023 | 438.86B | 52.31B | 13.53% |
| Mar 31, 2022 | 386.54B | 51.56B | 15.39% |
| Mar 31, 2021 | 334.98B | 6.61B | 2.01% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,553.24B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Life Insurance Corporation of India | 8,901.58B |
Sun Pharmaceutical Industries News
- 5 days ago - Nifty 50 top losers today, June 17: Adani Enterprises, Dr. Reddy’s, Tata Motors, Sun Pharma lead declines - Business Upturn
- 6 days ago - Nifty 50 top losers today, June 16: Tata Motors, Dr. Reddy’s, Sun Pharma, Adani Ports and Jio Financial Services - Business Upturn
- 7 days ago - UBS retains ‘Buy’ on Sun Pharma stock but awaits clarity on US drug tariffs - Business Upturn
- 7 days ago - Stocks to watch on June 17: Syngene, Tata Motors, Vedanta, YES Bank, SpiceJet, Sun Pharma, Natco Pharma, Zydus, Ramkrishna Forging - Business Upturn
- 8 days ago - Compliance review: Sun Pharma’s Halol plant gets 8 USFDA observations; company vows remedial steps after inspection - The Times of India
- 9 days ago - Sun Pharma’s Halol facility receives form 483 with 8 observations from US FDA - Business Upturn
- 9 days ago - Sun Pharma elevates Kirti Ganorkar as MD; Dilip Shanghvi to stay on as exec chairman - The Times of India
- 16 days ago - Nifty 50 top losers today, June 6: HDFC Life, Bharat Electronics, Bharti Airtel, Tata Steel and Sun Pharma - Business Upturn